Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Cash Flows from operating activities:
Net loss	$ (336,217)	$ (2,703,371)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	7,344	2,559
Net (gains) losses realized on the sale of securities	(52,397)	218,953
Unrealized (gains) losses on equity securities	(32,918)	1,151,808
Change in fair value of funds withheld embedded derivative	202,647
Amortization of investment securities, net	44,015	20,201
Deferred acquisition costs capitalized	(97,971)	(1,796,373)
Deferred acquisition costs amortized	270,057	575,210
Value of business acquired amortized	23,105	5,076
Interest credited on deposit type contracts	373,779	194,549
(Increase) decrease in operating assets:
Change in funds withheld	(584,526)
Investment income due and accrued	(50,084)	(33,166)
Reinsurance related assets	48,813	(70,088)
Other assets	1,120,029	(44,238)
Increase (decrease) in operating liabilities:
Policyowner benefit reserves	1,176,713	989,476
Dividend accumulation	929	(2,022)
Advance premiums	89,741	11,853
Other liabilities	9,632	82,893
Accounts payable and accrued expenses	(1,365,104)	40,416
Net cash provided by (used in) operating activities	847,587	(1,356,264)
Cash Flows from investing activities:
Purchase of fixed income investments		(876,333)
Purchase of equity investments	(139,813)	(2,974,768)
Purchase of mortgage investments	(391,388)
Proceeds from fixed income sales and repayments	183,632	523,611
Proceeds from equity sales	52,469	2,965,665
Proceeds from mortgage repayments	124,086
Transfers from (to) funds withheld	300,000
Interest on policy loans		(2,477)
Increase in policy loans	(2,978)	(20,243)
Net cash provided by (used in) investing activities	126,008	(384,545)
Cash Flows from financing activities:
Receipts on deposit-type contracts	972,879	2,944,455
Withdrawals on deposit-type contracts	(606,835)	(650,221)
Proceeds received from issuance of common stock, net of costs of issuance	(39,954)	(4,693)
Net cash provided by financing activities	326,090	2,289,541
Net increase in cash and cash equivalents	1,299,685	548,732
Cash and Cash Equivalents:
Beginning	4,320,759	6,678,805	6,678,805
Ending	5,620,444	7,227,537	$ 4,320,759
Supplemental Disclosure of Non-Cash Information
Funds withheld assumed deposits on deposit-type contracts	681,594,000
Funds withheld assumed withdrawals on deposit-type contracts	(155,649,000)
Commissions and expense allowances deducted from funds withheld	(276,279,000)
Reinsurer [Member]
Supplemental Disclosure of Non-Cash Information
Assumed deposit-type deposits due from reinsurer		$ 13,524,325,000